PDA calls for regulation of the business behaviours of pharmacy owners who damage the reputation of the profession.

The PDA welcomes this intervention because the reputation of members as professionals is impacted by the reputation of pharmacy in general. The PDA has previously raised concerns that the regulators have focussed too much on individuals and not enough on the employers. The PDA has previously highlighted how the GPhC identified over 650 major patient safety [...]

By |2020-07-02T12:12:06+01:00July 2nd, 2020|NIH News, Regional News|0 Comments

Community Pharmacy NI welcomes £13.25m funding commitment from Department of Health

Community Pharmacy NI has welcomed today’s announcement of £13.25m in funding for the community pharmacy network by the Department of Health.   Community Pharmacy NI is the professional membership body which represents over 500 local community pharmacies across Northern Ireland.   The funding allocation is set to help sustain and expand transformative services provided by [...]

By |2020-07-02T10:56:30+01:00July 2nd, 2020|NIH News, Regional News|0 Comments

AM Best Affirms Credit Ratings of Delta Dental of California and Its Affiliates

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” of Delta Dental of California (DDC) (San Francisco, CA) and its affiliates, Delta Dental Insurance Company (DDIC) (Wilmington, DE), Delta Dental of Pennsylvania (DDP) (Mechanicsburg, PA) and Delta Dental of New York, [...]

By |2020-07-01T03:05:09+01:00July 1st, 2020|NIH News|Comments Off on AM Best Affirms Credit Ratings of Delta Dental of California and Its Affiliates

Vertex Announces Expansion of Reimbursement Agreement With NHS England to Include KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With KALYDECO® (ivacaftor)

-CF patients in England will be among the first in Europe to benefit from access to KAFTRIO®, if the medicine is approved by the European Commission- LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has expanded its reimbursement agreement with NHS England for Vertex’s cystic fibrosis medicines to include KAFTRIO® (ivacaftor/tezacaftor/elexacaftor), in a [...]

By |2020-07-01T03:05:06+01:00July 1st, 2020|NIH News|Comments Off on Vertex Announces Expansion of Reimbursement Agreement With NHS England to Include KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With KALYDECO® (ivacaftor)

MWI Animal Health UK Launches New Technology-Enabled Solutions to Support Veterinary Clinic’s Virtual Healthcare Needs

CASTLE CARY, England--(BUSINESS WIRE)--MWI Animal Health UK, a leading animal health solutions company within the United Kingdom and a part of AmerisourceBergen, announced today the launch of new technology-enabled practice management solutions that will allow veterinarians to address specific health needs while staying virtually engaged with clients. The technology offerings will create seamless connectivity between [...]

By |2020-07-01T03:05:02+01:00July 1st, 2020|NIH News|Comments Off on MWI Animal Health UK Launches New Technology-Enabled Solutions to Support Veterinary Clinic’s Virtual Healthcare Needs

Rosemont Pharmaceuticals to Become Independent Business Following Acquisition by Private Equity Firm

Rosemont Pharmaceuticals will operate as an independent entity following acquisition a by Inflexion private equity. With more than 50 years’ experience and an extensive range of both licensed products and specials within the UK, Rosemont are the experts in liquid medicines with a portfolio of over 130 oral liquid medicines which includes over 70 licensed [...]

By |2020-06-29T13:45:16+01:00June 29th, 2020|NIH News, Regional News|0 Comments

Widely-Available Anti-Inflammatory Drug Effective in Treatment for COVID-19

Health Minister Robin Swann welcomes the announcement today that clinical trials found the drug Dexamethasone to be an effective treatment for Covid-19. Dexamethasone, an anti-inflammatory drug, has proven to reduce the risk of dying in COVID-19 patients on ventilation by as much as 35% and patients on oxygen by 20%. These results make it the world’s first [...]

By |2020-06-17T11:03:42+01:00June 17th, 2020|NIH News, Regional News|0 Comments

PDA launch COVID-19 risk management tool for community pharmacy

The PDA has launched a COVID-19 risk management tool designed to help responsible pharmacists and employers identify and remove risks in community pharmacy as lockdown restrictions are lessened. Mark Koziol, PDA Chairman said: "As the government has started to liberalise the lockdown, it is likely that the pharmacies will see even more activity. As healthcare [...]

By |2020-06-11T14:32:07+01:00June 11th, 2020|NIH News, Regional News|0 Comments

Minister Launches Strategic Framework for Rebuilding Services

Northern Ireland faces a massive challenge rebuilding health and social care in the wake of the first COVID-19 wave, Health Minister Robin Swann has stated. This rebuilding process can secure better ways of delivering services but will require innovation, sustained investment and society-wide support. Services will not be able to resume as before. Rebuilding will [...]

By |2020-06-09T12:54:49+01:00June 9th, 2020|NIH News, Regional News|0 Comments

Restarting cardiology services in the COVID-19 era

Menarini Farmaceutica Internazionale SRL has provided an educational grant to the BJC and Medinews (Cardiology) Limited to support the costs of running this webinar and related publications and has had no influence over the content or selection of speakers for the programme Sign up for our latest free webinar Thursday 18th June 2020 18.00 – [...]

By |2020-06-09T11:47:15+01:00June 9th, 2020|NIH News, Regional News|0 Comments